Separate spheres and indirect benefits
- PMID: 12773217
- PMCID: PMC156023
- DOI: 10.1186/1478-7547-1-4
Separate spheres and indirect benefits
Abstract
On any plausible account of the basis for health care resource prioritization, the benefits and costs of different alternative resource uses are relevant considerations in the prioritization process. Consequentialists hold that the maximization of benefits with available resources is the only relevant consideration. Non-consequentialists do not reject the relevance of consequences of benefits and costs, but insist that other considerations, and in particular the distribution of benefits and costs, are morally important as well. Whatever one's particular account of morally justified standards for the prioritization of different health interventions, we must be able to measure those interventions' benefits and costs.There are many theoretical and practical difficulties in that measurement, such as how to weigh extending life against improving health and quality of life as well as how different quality of life improvements should be valued, but they are not my concern here. This paper addresses two related issues in assessing benefits and costs for health resource prioritization. First, should benefits be restricted only to health benefits, or include as well other non health benefits such as economic benefits to employers from reducing the lost work time due to illness of their employees? I shall call this the Separate Spheres problem. Second, should only the direct benefits, such as extending life or reducing disability, and direct costs, such as costs of medical personnel and supplies, of health interventions be counted, or should other indirect benefits and costs be counted as well? I shall call this the Indirect Benefits problem. These two issues can have great importance for a ranking of different health interventions by either a cost/benefit or cost effectiveness analysis (CEA) standard.
Similar articles
-
[Evaluation of the burden of diabetes in Poland].Pol Arch Med Wewn. 2001 Sep;106(3):867-73. Pol Arch Med Wewn. 2001. PMID: 11928598 Polish.
-
Costs of illness in cost-effectiveness analysis. A review of the methodology.Pharmacoeconomics. 1994 Dec;6(6):536-52. doi: 10.2165/00019053-199406060-00007. Pharmacoeconomics. 1994. PMID: 10155283 Review.
-
The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental health.Psychopharmacol Bull. 1995;31(4):727-34. Psychopharmacol Bull. 1995. PMID: 8851646 Review.
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
Cited by
-
Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis.PLoS One. 2015 Dec 9;10(12):e0142691. doi: 10.1371/journal.pone.0142691. eCollection 2015. PLoS One. 2015. PMID: 26650078 Free PMC article.
-
Health Gains and Financial Protection Provided by the Ethiopian Mental Health Strategy: an Extended Cost-Effectiveness Analysis.Health Policy Plan. 2017 Apr 1;32(3):376-383. doi: 10.1093/heapol/czw134. Health Policy Plan. 2017. PMID: 27935798 Free PMC article.
-
Newborn health benefits or financial risk protection? An ethical analysis of a real-life dilemma in a setting without universal health coverage.J Med Ethics. 2018 Aug;44(8):524-530. doi: 10.1136/medethics-2017-104438. Epub 2018 Mar 30. J Med Ethics. 2018. PMID: 29602896 Free PMC article.
-
Given financial constraints, it would be unethical to divert antiretroviral drugs from treatment to prevention.Health Aff (Millwood). 2012 Jul;31(7):1537-44. doi: 10.1377/hlthaff.2012.0071. Health Aff (Millwood). 2012. PMID: 22778343 Free PMC article.
-
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19973. doi: 10.7448/IAS.18.4.19973. eCollection 2015. J Int AIDS Soc. 2015. PMID: 26198343 Free PMC article.
References
-
- Kamm FM. Morality, Mortality. Volume I: Death and Whom to Save From It? Oxford: Oxford University Press. 1993.
-
- Williams B. The Idea of Equality. In: Laslett P, Runciman WG, editor. Philosophy, Politics and Society, 2nd Series. Oxford: Basil Blackwell; 1962.
-
- Nozick R. Anarchy, State and Utopia. New York: Basic Books. 1974.
-
- Walzer M. Spheres of Justice: Defense of Pluralism and Equality. New York: Basic Books. 1983.
-
- Kagan S. The Limits of Morality. Oxford: Oxford University Press. 1989.
LinkOut - more resources
Full Text Sources
Miscellaneous